News
Ford's Q2 2025 sales soared, outpacing the industry with huge gains in trucks, hybrids, and SUVs thanks to a genius sales ...
Toyota scored more U.S. sales than Ford during Q2, but year-over-year numbers have shown that Ford is hot on its Japanese ...
Only three major automakers reported year-over-year sales growth in the U.S. during Q2, but their delivery percentage ...
Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.
The impact of tariffs is changing the automotive landscape. Here's how import and auto part tariffs are affecting new car ...
Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Abbott second-quarter results came in ahead of the consensus forecast, with its Medical Device business growing 13.4%.
StockStory.org on MSN5d
ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, ...
New data from online used car retailer cinch highlights a significant shift in consumer interest towards affordable electric ...
New-vehicle prices continued their slow upward climb in June, outpacing transaction prices as sales slow. According to new ...
Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results